Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 11/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.38 |
| ▸ | ACACB | O00763 | 3/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10303247 | 0.90 | FFAR1 (0.39) | FFAR1CNR2GPR119ACACBPDE4D | |
| SCHEMBL10303129 | 0.89 | FFAR1 (0.39) | FFAR1CNR2ACACBPDE4DPDE4B | |
| SCHEMBL10303246 | 0.89 | FFAR1 (0.38) | FFAR1GPR119ACACBPPARD | |
| SCHEMBL12907931 | 0.88 | MAOA (0.36) | FFAR1GPR119ACACB | |
| SCHEMBL12823094 | 0.88 | FFAR1 (0.43) | FFAR1CNR2GPR119ACACBPDE4D | |
| SCHEMBL10303165 | 0.88 | FFAR1 (0.42) | FFAR1ACACBPPARD | |
| SCHEMBL10302846 | 0.87 | CNR2 (0.40) | FFAR1CNR2PDE4DPDE4B | |
| SCHEMBL12223501 | 0.87 | CNR2 (0.40) | FFAR1CNR2PDE4DPDE4B | |
| SCHEMBL11939798 | 0.86 | FFAR4 (0.36) | FFAR1CNR2GPR119 | |
| SCHEMBL10303229 | 0.86 | FFAR1 (0.41) | FFAR1PDE4DPDE4BPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009125668-A1 | TRICYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | チッソ株式会社 (JP) | 2009-10-15 | — | — | WO | disclosed |